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Abstract  
 
Post-translational modification of proteins with glycosylation is of key importance in many 
biological systems in eukaryotes, influencing fundamental biological processes and regulating 
protein function. Changes in glycosylation are therefore of interest in understanding these processes 
and are also useful as clinical biomarkers of disease. The presence of glycosylation can also inhibit 
protease digestion and lower the quality and confidence of protein identification by mass 
spectrometry. While deglycosylation can improve the efficiency of subsequent protease digest and 
increase protein coverage, this step is often excluded from proteomic workflows. Here, we 
performed a systematic analysis that showed that deglycosylation with peptide-N-glycosidase F 
(PNGase F) prior to protease digestion with AspN or trypsin improved the quality of identification 
of the yeast cell wall proteome. The improvement in the confidence of identification of 
glycoproteins following PNGase F deglycosylation correlated with a higher density of glycosylation 
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sites. Optimal identification across the proteome was achieved with PNGase F deglycosylation and 
complementary proteolysis with either AspN or trypsin. We used this combination of 
deglycosylation and complementary protease digest to identify changes in the yeast cell wall 
proteome caused by lack of the Alg3p protein, a key component of the biosynthetic pathway of 
protein N-glycosylation. The cell wall of yeast lacking Alg3p showed specifically increased levels 
of Cis3p, a protein important for cell wall integrity. Our results showed that deglycosylation prior to 
protease digestion improved the quality of proteomic analyses even if protein glycosylation is not of 
direct relevance to the study at hand. 
 
 
Key words: ALG3; N-glycosylation; Saccharomyces cerevisiae; PNGase F; deglycosylation; 
proteomics 
  
Abbreviations used: OTase, oligosaccharyltransferase. 
 
 
 
 
 
 
 
 
 
 
 
 
 3 
1.0 Introduction 
 
Asparagine (N)-linked glycosylation of proteins is a common modification of secretory and 
membrane proteins in eukaryotes that is important for many aspects of glycoprotein function. The 
initial stages of N-glycoprotein biosynthesis occur in the endoplasmic reticulum (ER), where glycan 
to be transferred to protein is built on a lipid carrier by the consecutive action of a series of integral 
membrane glycosyltransferase enzymes [1]. The mature Glu3Man9GlcNAc2 glycan is efficiently 
transferred to asparagines in nascent polypeptides by the multiprotein enzyme complex 
oligosaccharyltransferase (OTase) [2, 3]. OTase preferentially binds asparagines located in 
‘glycosylation sequons’ (N-x-S/T; x≠P) at its peptide acceptor binding site, resulting in efficient 
modification of such sequences [4, 5]. The presence of N-glycans on nascent polypeptides assists 
productive protein folding in the ER directly by increasing the solubility of polypeptides, and 
indirectly through lectin-chaperone folding and quality control systems [6]. After glycoproteins 
leave the ER, their glycan structures are often further modified during transit through the Golgi. 
This can give rise to a very high diversity of glycan structures on mature proteins, which can affect 
glycoprotein function in many biological processes, including infection, development and cancer 
[7-9].  
 
N-glycosylation is also often used as an enrichment tag for reducing the complexity of protein 
samples [10-12]. Studies using such enrichment methods generally focus on the improvements in 
proteome depth and protein identification achievable through targeted enrichment of N-
glycopeptides, rather than the biology of N-glycosylation per se. However, in combination with 
sensitive and semi-quantitative selected reaction monitoring (SRM) detection, such methodologies 
offer substantial benefits for proteomic studies of a variety of clinically relevant sample types [13-
15]. 
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Because of its importance in diverse biological systems, protein N-glycosylation is of general 
interest in proteomic identification and protein characterisation studies. Changes in glycosylation 
have been associated with a wide variety of conditions including inherited disease, cancer and 
infection [7, 16-20]. However, relatively specialized sample preparation, detection methods and 
data analysis outside the scope of many studies are often required for detailed glycosylation 
analysis [21, 22]. In these cases, the N-glycosylation status of components of a sample is generally 
ignored. Nonetheless, even without a focus on identification or characterisation of N-glycosylation, 
many samples of interest for proteomic analysis are rich in N-glycoproteins. This includes clinical 
samples, tissue biopsies, cell culture material and many model organisms such as yeast. N-
glycosylation can influence proteomic analysis of such samples, as a key biological role of N-
glycosylation is to protect glycoproteins from proteolytic cleavage, an effect still present following 
protein denaturation. It has been reported that removal of N-glycans by glycosidases such as 
PNGase F can improve MS identification of N-glycoproteins [23-26]. However, a deglycosylation 
step is not generally included in proteomic workflows. Here, we performed a thorough systems-
level analysis of the benefit of inclusion of PNGase F deglycosylation prior to protease digestion 
with AspN and trypsin, in analysis of the cell wall proteome of Bakers’ yeast.  
 
 
2.0 Experimental  
2.1 Chemicals  
All chemicals were obtained from Sigma-Aldrich (St. Louis, Missouri, USA) unless otherwise 
specified, and were of analytical grade or higher. 
 
2.2 Yeast strains and growth conditions 
Saccharomyces cerevisiae strains used were BY4741 (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) and 
the Δalg3 mutant derivative thereof (Open Biosystems). Cells were grown to mid log phase as 
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measured by the optical density at 600nm at 30˚C in YPD (2% Bacto peptone, 1% yeast extract, and 
2% glucose) and cell wall protein samples immediately prepared. 
 
2.3 Cell wall protein sample preparation 
Preparation of proteins covalently linked to the yeast polysaccharide cell wall was performed as 
previously described [27, 28]. Biological triplicates of cells grown in 50 mL of YPD to mid log 
phase were harvested by centrifugation at 4000 rcf for 10 min, resuspended in 50 mM Tris-HCl 
buffer, pH 7.5, 1 mM phenylmethylsulfonyl fluoride (PMSF) and 1 x Complete protease inhibitor 
cocktail (Roche, Basel, Switzerland) and lysed by agitation using a Mo Bio Laboratories (Carlsbad, 
CA, USA) Vortex-Genie 2 at maximum speed with 425-600 µm glass beads for 1 h at 4˚C. 
Covalently linked cell wall material was pelleted by centrifugation at 18000 rcf for 1 min and 
washed 4 times with ice-cold 50 mM Tris-HCl buffer pH 7.5. The pellet was resuspended in 50 mM 
Tris-HCl buffer pH 8.0, 2 % sodium dodecyl sulfate (SDS), 7 M urea and 2 M thiourea. Cysteines 
were reduced and alkylated by addition of dithiothreitol to 10 mM and incubation at 30˚C with 
agitation at 1500 rpm in a Benchmark Scientific (South Plainfield, NJ, USA) Multi-Therm Heat-
Shake for 30 min, followed by addition of acrylamide to 50mM and further incubation with 
agitation at 30˚C for 1 h. Non-covalently linked proteins were removed by washing the 18000 rcf 
pellet five times with 1 ml 50mM Tris-HCl buffer, pH 8, 2 % SDS, 7 M urea and 2 M thiourea, 
followed by five washes with 2 % SDS. The pellet was resuspended in 100 µl 1% Tergitol-type 
nonyl phenoxypolyethoxylethanol (NP-40) and 1x G7 buffer (New England Biolabs, Ipswich, 
Massachusetts, USA) and aliquoted into 50 µl followed by addition of 500 units of PNGase F (New 
England Biolabs) and incubated at 37˚C with agitation at 1500 rpm in a Multi-Therm Heat-Shake 
for 16 h. Samples without PNGase F deglycosylation were incubated in the same buffer without 
PNGase F enzyme. Cell wall material was pelleted at 18000 rcf for 1 min and washed 5 times in 50 
mM Tris-HCl buffer pH 8.0. The final cell wall pellet, equivalent to 12.5 ml of cell culture, was 
resuspended in 50 mM NH4HCO3, and proteins were digested with either trypsin 4 µg/ml 
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(proteomics grade, Sigma) or AspN 1 µg/ml (proteomics grade, Promega) at 37˚C for 16 h with 
agitation at 1500 rpm in a Multi-Therm Heat-Shake.  
 
2.4 Mass Spectrometry 
Peptides were desalted using C18 ZipTips (Millipore, Billerica, Massachusetts, USA) and analyzed 
by LC-ESI-MS/MS using a Prominence nanoLC system (Shimadzu, Kyoto, Japan) direct on-line 
with a TripleTof 5600 mass spectrometer with a Nanospray III interface (AB SCIEX, Washington, 
D.C., USA) as previously described [27]. The Prominence nanoLC system consisted of a DGU-
20A5 degasser, two LC-20ADnano LC pumps, a SIL-20C HT autosampler, a CTO-20A column 
oven and a CBM-20A communications bus module. Approximately 2 µg peptides in 100 µl 5 % 
acetonitrile with 0.1 % formic acid were desalted on an Agilent Technologies (Santa Clara, 
California, USA) C18 trap (300 Å pore size, 5 µm particle size, 0.3 mm i.d. x 5 mm) at a flow rate 
of 30 µl/min for 3 min, and then separated on a Grace (Deerfield, Illinois, USA) Vydac EVEREST 
reversed-phase C18 HPLC column (300 Å pore size, 5 µm particle size, 150 µm i.d. x 150 mm) at 
45oC at a flow rate of 1 µl/min. Peptides were separated with a gradient of 10-60 % buffer B over 
45 min, with buffer A (1 % acetonitrile and 0.1 % formic acid) and buffer B (80 % acetonitrile with 
0.1 % formic acid). The TripleTof 5600 mass spectrometer was used in positive ion mode for 
information dependent acquisition (IDA) experiments performed in high-resolution mode with 
default settings. An MS TOF scan from m/z of 350-1800 was performed for 0.5 s followed by 
information dependent acquisition of MS/MS with automated selection of up to the top 20 peptides 
from m/z of 40-1800 for 0.05 s per spectrum. Nitrogen gas was used, and gas and voltage settings 
were adjusted as required. Typical values used were: IonSource Gas 1, 10 psi; Curtain Gas, 30 psi; 
IonSpray Voltage Floating, 2300 V; Interface Heating Temperature, 150oC, Declustering Potential, 
80 eV; Collision Energy (CE), 10 eV. Switch criteria for selection of ions for MS/MS were: Charge 
state, 2 to 5; Ion count exceeding 100 cps; excluding isotopes within 4 Da with a mass tolerance of 
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50 mDa; dynamic exclusion of former target ions for 30 s after 2 occurrences. CE for MS/MS was 
determined on-the-fly independently for each selected ion using rolling CE with default parameters. 
 
2.5 Data analysis 
Peptides were identified using ProteinPilot (AB SCIEX), searching the LudwigNR database 
(downloaded from http://apcf.edu.au as at 27 January 2012; 16,818,973 sequences; 5,891,363,821 
residues) with standard settings: Sample type, identification; Cysteine alkylation, acrylamide; 
Instrument, TripleTof 5600; Species, S. cerevisiae with common contaminants; ID focus, biological 
modifications; Enzyme, trypsin or AspN; Search effort, thorough ID. False discovery rate analysis 
using ProteinPilot was performed on all searches. Protein abundance was estimated from 
ProteinPilot search results using the values calculated by ProteinPilot for score, coverage or the 
number of peptides identified per protein. Peptides identified with greater than 95 % confidence and 
with a local false discovery rate of less than 1 % were included for further analysis, and MS/MS 
fragmentation spectra were manually inspected. Extracted ion chromatograms were obtained using 
PeakView 1.1 (AB SCIEX). Biological triplicates were analysed.  
 
 
3.0 Results and Discussion 
 
3.1 Protein identification.  
To gauge the benefit of including a PNGase F deglycosylation step prior to protease digestion in a 
proteomic workflow, we analysed the proteins covalently linked to the polysaccharide cell wall of 
Bakers’ yeast S. cerevisiae. This sample contains many N- and O-glycoproteins, as well as 
abundant non-glycosylated proteins [27-31]. This analysis robustly identified 26 proteins, with 19 
identified after both AspN and trypsin digest, four identified only by trypsin and three only by 
AspN (Supplementary Table S1, Supplementary material). The proteins identified were consistent 
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with previous proteomic analyses of yeast cell wall fractions [28, 32-34]. In addition, AspN digest 
allowed identification of Egt2p (Supplementary Table S1, Supplementary material), which was not 
identified in these previous studies. PNGase F treatment significantly improved protein 
identification in concert with either trypsin or AspN proteolytic digest (Fig. 1, Supplementary Table 
S1). Although no additional proteins were identified following PNGase F glycan release than 
without deglycosylation, the quality of identification of proteins was improved, as measured by 
protein score, percent peptide coverage and the number of confidently identified peptides (Fig. 1, 
Supplementary Table S1). 
 
The extent of the increase in the confidence of protein identification after PNGase F treatment 
correlated with the density of sites of N-glycosylation in a protein (Fig. 1). That is, the more 
glycosylation sequons per 100 amino acids in a protein, the greater the improvement in the 
confidence of identification a protein displayed upon deglycosylation. This association held with 
use of both trypsin and AspN as protease. Glycoproteins with more than 0.5 glycosylation sequons 
per 100 amino acids showed significantly more improvement in the confidence of identification 
with PNGase F treatment than proteins with fewer sequons, as measured by ProteinPilot score, 
coverage or the number of peptides identified per protein (Fig. 1D). In combination with trypsin, 
the correspondence between glycosylation site density and improvement in identification was 
essentially linear. This is consistent with glycan removal ‘unmasking’ otherwise undetectable 
tryptic glycopeptides [26], where there would be a linear relationship between the density of 
glycosylation sites and the number of additional peptides identifiable after glycan removal. In 
contrast, PNGase F in combination with AspN resulted in a positive but less direct correlation 
between confidence of identification and glycosylation site density (linear fit for coverage, R2 = 
0.63 for trypsin and 0.28 for AspN (Fig. 1)). This is most likely due to PNGase F glycan release 
converting glycosylated asparagine to aspartate, thereby generating novel AspN cleavage sites at 
each previously glycosylated asparagine residue. This PNGase F-mediated generation of additional 
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AspN cleavage sites potentially allows identification of two additional peptides per glycosylation 
site. However, both of these novel AspN peptides may not be of an m/z readily identifiable by MS, 
resulting in a more variable and protein-specific improvement in the confidence of identification. In 
general, PNGase F deglycosylation resulted in a larger improvement in identification with AspN 
than with trypsin, but with higher protein-specific variability. 
 
3.2 Protein characterisation.  
Within a given protein, identification of specific stretches of amino acids was highly 
complementary with AspN and trypsin cleavage. Ecm33p provides an example of this 
complementary characterisation (Fig. 2). Even though Ecm33p was identified with very high 
confidence with trypsin or AspN alone, the degree of characterisation of the protein was improved 
with use of both complementary treatments. Of 124 total amino acids present in peptides identified 
from Ecm33p, only 13 were detected by both AspN and trypsin, with 49 detected only by AspN and 
62 only by trypsin (Fig. 2C,D). PNGase F treatment further substantially improved coverage with 
both proteases. There were 254 amino acids present in peptides identified in total by AspN and 
trypsin after PNGase F deglycosylation, with 109 detected by both proteases, 78 only by AspN and 
67 only by trypsin (Fig. 2A,B). These results clearly show the advantages in protein characterisation 
of use of multiple proteases in conjunction with deglycosylation using PNGase F. Such improved 
peptide coverage through deglycosylation and protease complementarity may be of particular 
importance in detailed protein characterisation studies. This analysis also allowed putative 
identification of sites of N-glycosylation, by the conversion of previously glycosylated asparagine 
to aspartate by PNGase F deglycosylation (Fig. 2) [27]. However, validation of these glycosylation 
sites requires a negative control lacking PNGase F enzyme to ensure the observed deamidation 
events are not spontaneous [35], which occurs at asparagines in a sequence-dependent manner [36, 
37]. However, inclusion of such a control is not required for proteomic identification experiments, 
where mapping the precise sites of glycosylation is not of direct importance. 
 10 
 
 
3.3 Proteomic comparison of wild type and Δalg3 yeast cell wall composition.  
We used our method of deglycosylation with protease complementarity to characterise the 
consequences of loss of the Alg3p protein on the proteome of the yeast cell wall. The Alg3p protein 
in yeast is an integral membrane glycosyltransferase resident in the ER lumen, which catalyses 
transfer of a specific mannose monosaccharide to lipid linked glycan during synthesis of the glycan 
to be transferred to protein in N-glycosylation by OTase [38]. Lack of active Alg3p results in 
incomplete biosynthesis of this lipid linked glycan, and accumulation of a Man5GlcNAc2 glycan 
structure [39]. The activity of OTase is affected by the structure of glycan present, as OTase has 
high affinity for the mature lipid linked glycan, which limits transfer of the biosynthetic 
intermediates that are also present on the ER-lumenal face of the ER membrane. This means that 
OTase has reduced activity in the presence of incomplete glycan, for instance in Δalg3 cells lacking 
the Alg3p protein [27, 39]. We have previously shown that Δalg3 cells show site-specific under-
glycosylation, with the subset of normally glycosylated asparagine residues that are located in NxS 
sequons and in secondary structural elements tending to be under-glycosylated, compared with wild 
type yeast cells [27]. It is likely that this site-specific under-glycosylation phenotype is caused by 
reduced binding affinity of such protein acceptor sites to the active site of OTase [4]. Δalg3 Cells 
also show a slight growth sensitivity to calcofluor white, which is indicative of a cell wall defect 
[40], and a general reduction in glycosylation efficiency at multiple glycosylation sites in cell wall 
glycoproteins [27].  
 
We compared the cell wall proteome of wild type and Δalg3 yeast cells after PNGase F 
deglycosylation using either trypsin or AspN protease digest. No significant differences in protein 
abundance between Δalg3 and wild type cells were detected using deglycosylated tryptic peptides 
(Fig. 3A). However, a single protein, Cis3p (YJL158C; UniprotKB accession P47001; also known 
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as Ccw11p, Pir4p, Ccw5p, Scw8p) was upregulated in Δalg3 cells compared to wild type (P<0.05, 
ANOVA, Fig. 3B). Cis3p was also identified by tryptic digest, but did not show a significant 
change in expression between Δalg3 and wild type cells. To scrutinize this discrepancy, we 
examined the specific peptides identified from Cis3p by AspN and trypsin. This showed that the 
amino acid sequence of Cis3p is highly similar to other members of the PIR (protein with internal 
repeat) protein family, and as such many peptides are shared between members of this family, 
rather than being specific to a single protein. This is especially difficult for the abundant and highly 
similar Cis3p and Hsp150p (Pir2p) proteins (Fig 4A). This makes identification or unambiguous 
differentiation between these proteins difficult, as has been previously noted [32, 34]. Inspection of 
AspN peptides showed that two Cis3p-specific peptides were confidently identified 
(D164GPPPQAGAIYAAGWSITE182 and D207QNVAEQCSAIHLEAVSLV225), both of which 
showed large and significant upregulation in Δalg3 cells compared with wild type (Fig. 4). In 
contrast, only one tryptic peptide was unique to Cis3p (N132SGTLELTLK141), with another shared 
between Cis3p and Hsp150p (I152GSIVANR159) (Fig. 4). Of these, only the single Cis3p-unique 
tryptic peptide (N132-K141) showed large and significant upregulation in Δalg3 cells (Fig. 4B,D). 
The tryptic and AspN peptides from Hsp150p showed no significant change. Thus, Cis3p was not 
confidently identified as upregulated based on tryptic peptide identification, but the complementary 
analysis using AspN detected several unique peptides which did show significant upregulation in 
Δalg3 cells. 
 
Cis3p covalently links cell wall glucan through an alkali labile ester linkage [41] and is also cross 
linked to other cell wall proteins through disulfide bonds [42, 43] to increase the strength of the cell 
wall [44]. Deletion of CIS3 results in a mild growth defect compared to wild type cells and 
substantial changes in cell morphology resulting in increased cell clumping [45, 46]. 
Together with other members of the PIR family, gene expression studies have shown upregulation 
of Cis3p in response to cell wall stress caused by calcofluor white or zymolyase [47], or via the cell 
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wall integrity signalling pathway through Mpk1 [48]. A proteomic study showed upregulation of 
Cis3p and other proteins involved in the cell wall stability response in Δgas1 cells [34]. Gas1p is an 
abundant glycosyltransferase which plays a major role in cell wall remodelling during normal 
vegetative growth, and Δgas1 cells have a altered cell wall [49]. Hsp150p/Pir2p, a homolog of 
Cis3p, is upregulated in response to cell wall perturbation in response to beta 1,6-glucan deficiency 
[50]. In contrast, we did not detect significant changes in the expression of Hsp150p in Δalg3 cells. 
It is interesting that we detect specific upregulation of Cis3p, but not other PIR proteins, in Δalg3 
cells compared to wild type (Fig. 3, 4). This suggests that these proteins, although highly similar in 
sequence, are not completely functionally redundant, and that Cis3p plays an important role in 
response to the particular cell wall stresses present in Δalg3 cells. 
 
Δalg3 cells show underglycosylation at a specific subset of glycosylation sites [27], but do not show 
large changes in abundance of these cell wall glycoproteins (Fig. 3). However, upregulation of 
Cis3p suggests that the cell wall is somehow perturbed in Δalg3 cells, in agreement with previous 
reports [40]. This may be due to changes in the activity or stability of underglycosylated cell wall 
glycoproteins resulting in an altered and suboptimal cell wall structure. That is, underglycosylation 
of these glycoproteins in Δalg3 cells does not dramatically change their expression, but may affect 
their function. Alternatively, glycoproteins not covalently linked to the cell wall, but required for its 
synthesis, may have reduced expression, stability or function in Δalg3 cells. 
 
 
4.0 Conclusions 
Standard procedures for proteomic analysis generally do not include deglycosylation with PNGase 
F, and we show that treatment with PNGase F increases the confidence of identification in 
accordance with the density of glycosylation sites on proteins. Some proteins may be especially 
prone to improvements in identification following PNGase F digest. It is therefore advantageous to 
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deglycosylate with PNGase F even if N-glycosylation is not a focus of a proteomic experiment, in 
samples which contain moderately or highly glycosylated proteins. This would include most 
secreted or membrane protein samples in eukaryotic biochemical analysis or clinical biomarker 
discovery samples. Protease digestion with a combination of complementary specific proteases can 
allow improved protein characterisation, especially AspN in combination with PNGase F. We used 
these approaches to show that the stress response protein Cis3p is a key component of the yeast cell 
wall stress response to reduced N-glycosylation with loss of ALG3 in yeast. 
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Figure legends 
 
Figure 1. PNGase F digest improves identification of yeast cell wall glycoproteins using AspN or 
trypsin. Ratio of (A) score, (B) coverage and (C) number of peptides identified for each protein in 
PNGase F treated samples relative to nontreated control samples, in combination with AspN () or 
trypsin () digest. (D) Average ratio of score, coverage and number of peptides identified in 
PNGase F treated samples relative to nontreated control samples, in combination with AspN “A” or 
trypsin “T” digest, for proteins with high (greater than 0.5 glycosylation sequons per 100 amino 
acids, black) or low (fewer than 0.5 glycosylation sequons per 100 amino acids, white) 
glycosylation site density. Values show mean. Error bars show standard deviation. *, P<0.05 
Students T-test. 
 
Figure 2. Coverage of Ecm33p (A) with and (C) without PNGase F digest using AspN or Trypsin. 
Bold, identified with trypsin. Underlined, identified with AspN. Italic N, deamidated asparagine 
indicating location of a putative N-glycosylation site. (B) Number of amino acids contained in 
peptides identified after PNGase F deglycosylation and AspN or trypsin digest or (B) without 
PNGase F deglycosylation. 
 
Figure 3. Relative abundance of cell wall proteins in Δalg3 and wild type yeast. Natural logarithm 
of the ratios of protein identification scores from Δalg3 relative to wild type yeast after PNGase F 
deglycosylation and protease digest with (A) trypsin or (B) AspN. Values show mean. Error bars 
show standard deviation. *, significantly upregulated in Δalg3 cells (ANOVA, P<0.05).  
 
Figure 4. Relative abundance of the highly similar Cis3p and Hsp150p proteins in Δalg3 and wild 
type yeast cell wall preparations. (A) ClustalW alignment of the C-terminal region of yeast Cis3p 
and Hsp150p. Bold, identified tryptic peptides. Underlined, identified AspN peptides. (B) Extracted 
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ion chromatograms from wild type (solid) and Δalg3 (dashed) yeast of the [M+2H]2+ ion at an m/z 
of 950.95 corresponding to AspN peptide 164DGPPPQAGAIYAAGWSITE182 specific for Cis3p, 
and (C) the  [M+2H] 2+ ion at an m/z of 415.24 corresponding to tryptic peptide IGSIVANR shared 
by Cis3p (52-59) and Hsp150p (338-345). (D) Natural logarithm of the ratio of abundance of ions 
corresponding to peptides from Cis3p and/or Hsp150p in Δalg3 cells relative to wild type cells. 
Values show mean of biological triplicate. Error bars show standard deviation.  
 
 21 
Figure 1 
 
 
 22 
Figure 2 
 
 
 23 
Figure 3 
 
 
 24 
Figure 4 
 
 
